Product correctly added to cart.

discount label
Timolol related compound C
View 3D

Biosynth logo

Timolol related compound C

CAS: 610271-57-3

Ref. 3D-KZA27157

1mgTo inquire
5mgTo inquire
10mgTo inquire
25mgTo inquire
50mgTo inquire
Estimated delivery in United States, on Monday 26 Aug 2024

Product Information

Name:
Timolol related compound C
Description:

Timolol is a beta-adrenergic blocker that is used to treat glaucoma and other eye conditions by reducing intraocular pressure. Timolol related compound C (TRC) is a beta-adrenergic receptor antagonist that is being investigated for its ability to reduce intraocular pressure. TRC has been shown to be effective in animal models of glaucoma. In one study, the drug was administered at concentrations of 0.1 mg/mL or 1 mg/mL with dorzolamide hydrochloride, a carbonic anhydrase inhibitor, and brimonidine, an alpha-2 adrenergic agonist. The concentration-time curve showed that the drugs were well tolerated and produced no adverse effects on ocular tissue. These results suggest that TRC may be a possible treatment for glaucoma patients who are resistant to current therapies such as timolol or beta-blockers.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
601.7 g/mol
Formula:
C23H35N7O8S2
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-KZA27157 Timolol related compound C

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".